Fund shareholders of Bristol-Myers Squibb Co
ISIN US1101221083 · United States · LEI HLYYNH7UQUORYSJQCN42
- Fund shareholders
- 1,258
- Of which ETFs
- 356 902 other funds
- Value held
- 37B $ 7.2B SEK · 100.6M €
- Share of capital
- 30.3 % of 2B shares on Jul 22, 2026
This issuer has other securities : Bristol-Myers Squibb Company (US1101221406)
1,258 funds hold this company. This table lists the 1,246 that declare it in a regulatory filing. The other 12 publish their holdings in their own reports. They are not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Cyber Hornet S&P 500 & Solana 75/25 Strategy ETF Cyber Hornet Trust | 13 | 788.5 $ | 0.17 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Cyber Hornet S&P 500 & XRP 75/25 Strategy ETF Cyber Hornet Trust | 13 | 788.5 $ | 0.17 % | 0.00 % | as of Mar 31, 2026 ↗ |
| MI CARTERA RV USA ADVISED BY, FI SANTANDER ASSET MANAGEMENT, S.A., SGIIC | 27M € | 1.43 % | as of Dec 31, 2025 ↗ | ||
| KUTXABANK BOLSA EEUU, FI KUTXABANK GESTION, SGIIC, S.A. | 19.8M € | 1.16 % | as of Dec 31, 2025 ↗ | ||
| FONDMAPFRE BOLSA AMERICA, FI MAPFRE ASSET MANAGEMENT, SGIIC, S.A. | 12.1M € | 1.94 % | as of Dec 31, 2025 ↗ | ||
| CAIXABANK MULTISALUD, FI CAIXABANK ASSET MANAGEMENT SGIIC, S.A. | 8.9M € | 1.35 % | as of Dec 31, 2025 ↗ | ||
| BBVA GLOBAL DESARROLLO, FI BBVA ASSET MANAGEMENT, S.A., SGIIC | 5.3M € | 0.70 % | as of Dec 31, 2025 ↗ | ||
| BBVA USA DESARROLLO, FI BBVA ASSET MANAGEMENT, S.A., SGIIC | 5.1M € | 0.80 % | as of Dec 31, 2025 ↗ | ||
| IBERCAJA SANIDAD, FI IBERCAJA GESTION, SGIIC, S.A. | 5M € | 1.66 % | as of Dec 31, 2025 ↗ | ||
| BINDEX USA INDICE, FI BBVA ASSET MANAGEMENT, S.A., SGIIC | 2.2M € | 0.18 % | as of Dec 31, 2025 ↗ | ||
| ING DIRECT FONDO NARANJA STANDARD & POOR´S 500, FI AMUNDI IBERIA, SGIIC, S.A. | 1.9M € | 0.18 % | as of Dec 31, 2025 ↗ | ||
| IBERCAJA BOLSA USA, FI IBERCAJA GESTION, SGIIC, S.A. | 1.7M € | 0.43 % | as of Dec 31, 2025 ↗ | ||
| MORINVEST, SICAV, S.A. BBVA ASSET MANAGEMENT, S.A., SGIIC | 1.5M € | 0.23 % | as of Dec 31, 2025 ↗ | ||
| FONDMAPFRE GLOBAL, FI MAPFRE ASSET MANAGEMENT, SGIIC, S.A. | 1.4M € | 0.39 % | as of Dec 31, 2025 ↗ | ||
| BBVA USA DESARROLLO CUBIERTO, FI BBVA ASSET MANAGEMENT, S.A., SGIIC | 1.1M € | 0.79 % | as of Dec 31, 2025 ↗ | ||
| ROMERO INVERSIONES MOBILIARIAS, SICAV S.A. SANTANDER ASSET MANAGEMENT, S.A., SGIIC | 642.9K € | 2.62 % | as of Dec 31, 2025 ↗ | ||
| MERCHFONDO, FI ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 618.5K € | 0.36 % | as of Dec 31, 2025 ↗ | ||
| GESIURIS HEALTHCARE & INNOVATION FI GESIURIS ASSET MANAGEMENT, SGIIC, S.A. | 597K € | 3.34 % | as of Dec 31, 2025 ↗ | ||
| FONDMAPFRE RENTA MIXTO, FI MAPFRE ASSET MANAGEMENT, SGIIC, S.A. | 543.2K € | 0.31 % | as of Dec 31, 2025 ↗ | ||
| SIGMA INVESTMENT HOUSE HEALTHCARE, FI ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 543.1K € | 1.39 % | as of Dec 31, 2025 ↗ | ||
| MUTUAFONDO SALUD, FI MUTUACTIVOS, S.A., S.G.I.I.C. | 483.2K € | 2.71 % | as of Dec 31, 2025 ↗ | ||
| BBVA BOLSA INDICE USA (CUBIERTO), FI BBVA ASSET MANAGEMENT, S.A., SGIIC | 469K € | 0.18 % | as of Dec 31, 2025 ↗ | ||
| RENTA 4 MEGATENDENCIAS, FI RENTA 4 MEGATENDENCIAS / SALUD, INNOVACIÓN Y BIOTECNOLOGÍA MÉDICA RENTA 4 GESTORA, S.G.I.I.C., S.A. | 399K € | 2.00 % | as of Dec 31, 2025 ↗ | ||
| FONDMAPFRE ELECCION MODERADA, F.I. MAPFRE ASSET MANAGEMENT, SGIIC, S.A. | 344.4K € | 0.10 % | as of Dec 31, 2025 ↗ | ||
| SIGMA INVESTMENT HOUSE CAPITAL, FI ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 315.7K € | 0.28 % | as of Dec 31, 2025 ↗ | ||
| FONDMAPFRE ELECCION PRUDENTE, F.I. MAPFRE ASSET MANAGEMENT, SGIIC, S.A. | 302.6K € | 0.10 % | as of Dec 31, 2025 ↗ | ||
| BINDEX USA SCREENED ÍNDICE (CUBIERTO), FI BBVA ASSET MANAGEMENT, S.A., SGIIC | 219K € | 0.26 % | as of Dec 31, 2025 ↗ | ||
| INVERSABADELL 25, FI SABADELL ASSET MANAGEMENT, S.A., S.G.I.I.C. | 194K € | 0.03 % | as of Dec 31, 2025 ↗ | ||
| RENTA 4 GLOBAL ACCIONES, FI RENTA 4 GESTORA, S.G.I.I.C., S.A. | 189.9K € | 0.37 % | as of Dec 31, 2025 ↗ | ||
| CBNK SELECCIÓN, FI CBNK SELECCIÓN / SALUD CBNK GESTION DE ACTIVOS, S.G.I.I.C., S.A. | 169K € | 2.44 % | as of Dec 31, 2025 ↗ | ||
| TOP CLASS HEALTHCARE, FI RENTA 4 GESTORA, S.G.I.I.C., S.A. | 160.7K € | 1.20 % | as of Dec 31, 2025 ↗ | ||
| FONDMAPFRE ELECCIÓN DECIDIDA, F.I. MAPFRE ASSET MANAGEMENT, SGIIC, S.A. | 152.5K € | 0.15 % | as of Dec 31, 2025 ↗ | ||
| FINECO INVESTMENT OFFICE, FI FINECO INVESTMENT OFFICE/SCHRODERS G.I.I.C. FINECO, S.A., S.G.I.I.C. | 151.9K € | 0.14 % | as of Dec 31, 2025 ↗ | ||
| ADRIZA GLOBAL, FI TRESSIS GESTION, S.G.I.I.C., S.A. | 149.2K € | 0.28 % | as of Dec 31, 2025 ↗ | ||
| COMPROMISO MEDIOLANUM, FI MEDIOLANUM GESTION, S.G.I.I.C., S.A. | 147.5K € | 0.36 % | as of Dec 31, 2025 ↗ | ||
| INVERSABADELL 50, FI SABADELL ASSET MANAGEMENT, S.A., S.G.I.I.C. | 141.2K € | 0.06 % | as of Dec 31, 2025 ↗ | ||
| ANNUALCYCLES STRATEGIES, FI GESIURIS ASSET MANAGEMENT, SGIIC, S.A. | 114.8K € | 0.42 % | as of Dec 31, 2025 ↗ | ||
| CARTERA SMART GESTION SICAV, S.A. INVERSIS GESTIÓN, S.A., SGIIC | 114.8K € | 1.14 % | as of Dec 31, 2025 ↗ | ||
| SMART GESTION FLEXIBLE, FI INVERSIS GESTIÓN, S.A., SGIIC | 91.8K € | 0.91 % | as of Dec 31, 2025 ↗ | ||
| SABADELL PLANIFICACION, FI SABADELL ASSET MANAGEMENT, S.A., S.G.I.I.C. | 60K € | 0.03 % | as of Dec 31, 2025 ↗ | ||
| GESTION BOUTIQUE VI, FI GESTION BOUTIQUE VI / NOAX GLOBAL ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 53.2K € | 3.14 % | as of Dec 31, 2025 ↗ | ||
| INVERSABADELL 70, FI SABADELL ASSET MANAGEMENT, S.A., S.G.I.I.C. | 50.1K € | 0.08 % | as of Dec 31, 2025 ↗ | ||
| MULTIADVISOR GESTION, FI MULTIADVISOR GESTION / SMART GESTION ESTRATEGIA GLOBAL INVERSIS GESTIÓN, S.A., SGIIC | 37.9K € | 1.09 % | as of Dec 31, 2025 ↗ | ||
| TULIACAN, SICAV, S.A. ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 30.3K € | 0.38 % | as of Dec 31, 2025 ↗ | ||
| ATL CAPITAL CARTERA DINAMICA, FI ATL 12 CAPITAL GESTION S.G.I.I.C, S.A. | 20.3K € | 0.05 % | as of Dec 31, 2025 ↗ | ||
| MARKET PORTFOLIO EQUITY, F.I. MARKET PORTFOLIO ASSET MANAGEMENT, S.G.I.I.C., S.A. | 15.7K € | 0.03 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| First Trust Nasdaq Pharmaceuticals ETF First Trust Exchange-Traded Fund VI | 7.36 % | as of Mar 31, 2026 ↗ |
| Independent Franchise Partners US Equity Fund Advisers Investment Trust | 6.29 % | as of Mar 31, 2026 ↗ |
| Invesco S&P Ultra Dividend Revenue ETF Invesco Exchange-Traded Fund Trust II | 5.52 % | as of Feb 28, 2026 ↗ |
| Integrity Dividend Summit Fund INTEGRITY FUNDS | 5.30 % | as of Apr 30, 2026 ↗ |
| Horizon Kinetics Medical ETF Listed Funds Trust | 5.13 % | as of Mar 31, 2026 ↗ |
| VanEck Morningstar Wide Moat Value ETF VanEck ETF Trust | 4.89 % | as of Mar 31, 2026 ↗ |
| Calvert Focused Value Fund Calvert Social Investment Fund | 4.66 % | as of Mar 31, 2026 ↗ |
| iShares U.S. Pharmaceuticals ETF iShares Trust | 4.63 % | as of Mar 31, 2026 ↗ |
| VanEck Pharmaceutical ETF VanEck ETF Trust | 4.62 % | as of Mar 31, 2026 ↗ |
| Brookstone Value Stock ETF Northern Lights Fund Trust IV | 4.42 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 1,129 | +80 | 606,752,816 | +2.3 % |
| 2026Q1 | 1,049 | +7 | 593,078,761 | -5.4 % |
| 2025Q4 | 1,042 | -15 | 626,650,290 | -7.3 % |
| 2025Q3 | 1,057 | +21 | 675,860,074 | +0.2 % |
| 2025Q2 | 1,036 | +30 | 674,780,424 | +3.1 % |
| 2025Q1 | 1,006 | -23 | 654,214,076 | +2.4 % |
| 2024Q4 | 1,029 | +8 | 638,808,083 | +0.0 % |
| 2024Q3 | 1,021 | -76 | 638,566,608 | +1.1 % |
| 2024Q2 | 1,097 | +9 | 631,499,108 | +3.3 % |
| 2024Q1 | 1,088 | -53 | 611,198,774 | -3.9 % |
| 2023Q4 | 1,141 | 636,138,480 |
Institutional managers
2,491 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 171,682,888 | 10.4B $ | as of Mar 31, 2026 |
| STATE STREET CORP | 98,564,914 | 6B $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 92,475,194 | 5.5B $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 61,115,373 | 3.7B $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 55,286,174 | 3.3B $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 32,586,981 | 2B $ | as of Mar 31, 2026 |
| AQR CAPITAL MANAGEMENT LLC | 29,631,105 | 1.8B $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 29,198,554 | 1.8B $ | as of Mar 31, 2026 |
| AMERIPRISE FINANCIAL INC | 26,470,718 | 1.6B $ | as of Mar 31, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | 24,985,149 | 1.5B $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 24,758,771 | 1.5B $ | as of Mar 31, 2026 |
| Bank of New York Mellon Corp | 23,301,337 | 1.4B $ | as of Mar 31, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 22,719,320 | 1.4B $ | as of Mar 31, 2026 |
| Independent Franchise Partners LLP | 21,275,474 | 1.3B $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 18,762,589 | 1.1B $ | as of Mar 31, 2026 |
| PZENA INVESTMENT MANAGEMENT LLC | 17,095,731 | 1B $ | as of Mar 31, 2026 |
| Legal & General Group Plc | 16,877,626 | 1B $ | as of Mar 31, 2026 |
| Invesco Ltd. | 15,509,999 | 940.7M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 14,054,518 | 852.4M $ | as of Mar 31, 2026 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 12,235,494 | 742.1M $ | as of Mar 31, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | 11,887,668 | 720.9K $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 11,535,106 | 699.6M $ | as of Mar 31, 2026 |
| ROYAL BANK OF CANADA | 10,958,702 | 664.6M $ | as of Mar 31, 2026 |
| FMR LLC | 10,671,103 | 647.2M $ | as of Mar 31, 2026 |
| VAN ECK ASSOCIATES CORP | 10,257,215 | 622.1K $ | as of Mar 31, 2026 |
Declared shareholders of Bristol-Myers Squibb Co
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Vanguard Capital Management | 7.49 % | 153,108,018 | as of Mar 31, 2026 · SCHEDULE 13G |
Funds holding the debt of Bristol-Myers Squibb Co
336 funds declare 1,427 bond lines of this company. The table shows the 25 largest holdings. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
Cite this page
Titelia. "Fund shareholders of Bristol-Myers Squibb Co". https://titelia.com/en/stocks/bristol-myers-squibb-co-US1101221083